uniQure
QURE
13,01 €
Share price
1.15%
Change (1 day)
197.93%
Change (1 year)
uniQure (QURE) - Total assets
Total assets on the balance sheet as of March 2025 : €0.52 Billion
According to uniQure's latest financial reports the company's total assets are €0.52 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
uniQure - Total assets on balance sheet (from 2012 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | €0.53 B | -28.91% |
| 2023-12-31 | €0.75 B | 14.48% |
| 2022-12-31 | €0.65 B | -8.02% |
| 2021-12-31 | €0.71 B | 158.18% |
| 2020-12-31 | €0.27 B | -30.9% |
| 2019-12-31 | €0.40 B | 67.26% |
| 2018-12-31 | €0.23 B | 37.03% |
| 2017-12-31 | €0.17 B | -3.41% |
| 2016-12-31 | €0.18 B | -24.7% |
| 2015-12-31 | €0.24 B | 150.83% |
| 2014-12-31 | €95.77 M | 145.79% |
| 2013-12-31 | €38.96 M | 600.07% |
| 2012-12-31 | €5.56 M | -3.91% |
| 2011-12-31 | €5.79 M | -74.48% |
| 2010-12-31 | €22.7 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | €77.71 B | 14,661.57% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | €74.92 M | -85.77% | 🇺🇸 USA |
 bluebird bio
BLUE | €0.25 B | -51.11% | 🇺🇸 USA |
 Avidity Biosciences RNA | €1.26 B | 141.01% | 🇺🇸 USA |
 Sanofi SNY | €124.14 B | 23,480.82% | 🇫🇷 France |
 BioMarin Pharmaceutical BMRN | €6.21 B | 1,080.54% | 🇺🇸 USA |